[HTML][HTML] Terbium radionuclides for theranostic applications in nuclear medicine: from atom to bedside
C Van Laere, M Koole, CM Deroose… - Theranostics, 2024 - ncbi.nlm.nih.gov
Terbium features four clinically interesting radionuclides for application in nuclear medicine:
terbium-149, terbium-152, terbium-155, and terbium-161. Their identical chemical properties …
terbium-149, terbium-152, terbium-155, and terbium-161. Their identical chemical properties …
Macrocyclic 1, 2-Hydroxypyridinone-based chelators as potential ligands for Thorium-227 and Zirconium-89 radiopharmaceuticals
Thorium-227 (227Th) is an α-emitting radionuclide that has shown preclinical and clinical
promise for use in targeted α-therapy (TAT), a type of molecular radiopharmaceutical …
promise for use in targeted α-therapy (TAT), a type of molecular radiopharmaceutical …
Evaluation of a novel hexadentate 1, 2-hydroxypyridinone-based acyclic chelate, HOPO-O6-C4, for 43Sc/47Sc, 68Ga, and 45Ti radiopharmaceuticals
I Carbo-Bague, S Saini, SJ Cingoranelli… - Nuclear Medicine and …, 2024 - Elsevier
Introduction Chelators play a crucial role in the development of metal-based
radiopharmaceuticals, and with the continued interest in 68 Ga and increasing availability of …
radiopharmaceuticals, and with the continued interest in 68 Ga and increasing availability of …